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In Brief
The Neuroscience Revolution
While the world's attention hasbeen diverted by the drama of
the Human Genome Project, neuro-
science has been quiedy creating a revo-
lution with implications every bit as
profound as those of genetics. Neu-
roimaging advances, psychopharmaceu-
ticals with enormous potential for clini-
cal use, neural-technological interfaces,
brain stimulation technologies, and or-
ganic implants such as fetal cell therapy
are transforming our ability to under-
stand and intervene in the brain. Along
the way, they are also challenging ac-
cepted standards for the proper limits of
technology, possibly giving criminal jus-
tice some revolutionary and troubling
new tools, redefming our sense of self-
hood and brain-body relations, and rais-
ing a host of other ethical and social
questions. And all this without a multi-
billion dollar, public-private juggernaut
like the Human Genome Project to
drive it forward.
Ethicists are only now beginning to
take note of these developments. Two
recent conferences, one on each coast,
have raised a call to ethicists by high-
lighting the astonishing scientific ad-
vances in neurosciences and the oft-
times novel ethical challenges they pre-
sent.
The first conference, funded by the
Greenwall and Medtronic Foundations
and hosted in February 2000 by the
University of Pennsylvania's Center for
Bioethics and Center for Cognitive
Neuroscience, was the culmination of a
series of meetings of ethicists and neuro-
scientists in early 2000. A larger, more
ambitious conference took place in San
Francisco in May, sponsored by the
Dana Foundation and hosted jointly by
Stanford and the University of Califor-
nia at San Francisco. Promising to kick-
start the "new field of neuroethics," the
conference included leaders in neuro-
science, law, social science, and ethics—
and William Safire as master of cere-
monies. The two conferences explored
issues such as the proper use of psy-
chopharmaceuticals, the proper role of
physicians in dispensing neuroactive
drugs, the nature of human rights and
responsibilities, the proper use of neuro-
diagnostics (for example, for predicting
a child's susceptibility to a late-onset
disease like Alzheimers), public dis-
course and social policy, and the proper
nature and limits to the practice of sci-
ence.
The increasing attention to neuro-
science is not surprising given the novel
problems of these technologies. Neu-
roimaging studies are beginning to
demonstrate an ability to correlate men-
tal states and traits to detectable brain
patterns or structures. Research has
shown, for example, that a history of
depression, or addiction, leaves identifi-
able brain sequelae even if the disease is
in remission. In some cases, neuroimag-
ing may be able to detect racist ideation,
to diflFerentiate false and true memories,
and to discover mood states (even when
they are preconscious in the subject), in-
tentional prevarication, and even the
content of thought (to discover whether
someone is thinking of a face or a chair,
for example). While these studies are
preliminary and their powers of predic-
tion so far modest, they portend a time
when the criminal justice system, em-
ployers, schools, and other institutions
may want to use imaging to detect or re-
fute other kinds of evidence about peo-
ple's aptitudes, honesty, or history.
In addition to these diagnostic or
scanning technologies, new psy-
chopharmaceuticals are promising to re-
define how we conceive of disease, treat-
ment, and professional privilege. Drugs
like Prozac, Viagra, and soon perhaps
modafinil (which fights fatigue without
the side effects of amphetamines), are
being used by people without any diag-
nosable pathology, and are often pre-
scribed by physicians upon request.
Drugs are being developed that can en-
hance memory, confidence, and other
aspects of normal functioning and will
likely be as freely available as Viagra,
which can now be purchased on the
web with at best a transparent nod to
diagnostic and prescriptive require-
ments. As the power and specificity of
these drugs increase, so will the ability
of the average person to manage his
daily life pharmacologically, adding a
host of mood and cognitive enhancers
to the morning cup of coffee and the
after-work cocktail.
Neuroimaging and psychopharma-
ceuticals are only the tip of the neuro-
science iceberg. Implantable computer
"brain chips" are allowing the blind to
see, the deaf to hear, and monkeys to
control cursors on computer screens en-
tirely with their minds. Trans-cranial
magnetic stimulation can temporarily
turn specific areas of the brain off by
sending electric charges through the
skull. Electrode implantation has al-
lowed scientists to create "robo-rats"
whose travels are controlled by the joy-
sticks of scientists, and monkeys whose
thought processes can control mechani-
cal arms thousands of miles away.
Clearly the influence of these tech-
nologies on everyday life is only years
away, rather than decades, as in the case
of genetic technologies. Bioethicists are
coming to the game a bit late, and often
underprepared, but the issues are real
and complex, and the neuroscientists
are not waiting for the ethical ground-
work to be laid.
—Paul Root Wolpe
University of Pennsylvania
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